Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

Franklin Rising Dividends Fund A

The Health Care Select Sector SPDR® ETF

Vanguard Institutional Index I

Vanguard Dividend Appreciation ETF

JPM US Equity Income-Composite

JPMorgan Equity Income I

State St S&P 500® Indx SL Cl III

Columbia Dividend Value

JNL/T. Rowe Price Capital Appreciation A

T. Rowe Price US Lg-Cp Equity Inc Comp

T. Rowe Price Capital Appreciation

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

iShares Core S&P 500 ETF

Morgan Stanley Glbl Franchise

MS INVF Global Brands A

Vanguard Value Index Inv

First Eagle Global A

Vanguard Group Inc

BlackRock Inc

JPMorgan Chase & Co

Amvescap Plc.

Arnhold & S. Bleichroeder Advisers, LLC

NORGES BANK

ClearBridge Advisors, LLC

Charles Schwab Investment Management Inc

Ameriprise Financial Inc

Amundi

Mitsubishi UFJ Asset Management Co.,Ltd

Franklin Resources Inc

State Street Corp

T. Rowe Price Associates, Inc.

Morgan Stanley - Brokerage Accounts

T. Rowe Price Investment Management,Inc.

Geode Capital Management, LLC

Generation Investment Management LLP

Massachusetts Financial Services Company

Bank of New York Mellon Corp

Becton Dickinson and Company

Mr. Thomas E. Polen Jr.

President, CEO & Chairman

Ms. Shana Carol Neal

Executive VP & Chief People Officer

Mr. Michael  Garrison

Executive VP & President of Medical segment

Mr. Thomas J. Spoerel

Senior VP, Controller & Chief Accounting Officer

Ms. Elizabeth  McCombs

Executive VP & Chief Technology Officer

Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.

Senior VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board

Ms. Denise Russell Fleming

Executive VP of Technology & Global Services and Chief Information Officer

Mr. Greg  Rodetis

Head of Investor Relations

Ms. Michelle  Quinn

Executive VP & General Counsel

Claudia  Curtis

Senior VP, Chief Ethics & Compliance Officer

BDX's next earnings is on January 30, 2025 (Before Market Open)

BDX's latest dividend is 0.95 USD on September 9, 2024

Becton Dickinson and Company (BDX) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Becton Dickinson and Company (BDX) Earnings Report Date and History | NYSE

BDX's next earnings is on January 30, 2025 (Before Market Open)

When is the earnings report for BDX?

BDX Earnings History

BDX's latest dividend is 0.95 USD on September 9, 2024

BDX Stock Discussion Forum and Message Board

News for NYSE: BDX